Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
SWOG Cancer Research Network
Xinqiao Hospital of Chongqing
Advaxis, Inc.
Novartis
Eastern Cooperative Oncology Group
Agenus Inc.
The First Affiliated Hospital with Nanjing Medical University
Bristol-Myers Squibb
GU Research Network, LLC
University of California, San Francisco
NextCure, Inc.
Hoffmann-La Roche
Saint John's Cancer Institute
Incyte Corporation
Incyte Corporation
Queen Mary University of London
The Netherlands Cancer Institute
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Vanderbilt-Ingram Cancer Center
Louisiana State University Health Sciences Center Shreveport
University of Michigan Rogel Cancer Center
University of Southern California
University of Southern California
Memorial Sloan Kettering Cancer Center
Emory University
Aktion Bronchialkarzinom e.V.
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
University College, London